Michiel Andy Hu

Michiel Andy Hu

Auto-generated profile, based on publicly available information

Michiel Andy Hu

Department of Thoracic Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
NMNiels Moeslund
Niels Moeslund
IEImran A. Ertugrul
Imran A. Ertugrul
MHMichiel A. Hu
Michiel A. Hu
FDFrederik Flyvholm Dalsgaard
Frederik Flyvholm Dalsgaard
LILars Bo Ilkjaer
Lars Bo Ilkjaer
HEHans Eiskjaer
Hans Eiskjaer
Heart transplantation in donation after circulatory death (DCD) relies on warm perfusion using either in situ normothermic regional perfusion (NRP) or ex situ normothermic machine perfusion. In this study, we explore an alternative: oxygenated hypothermic machine perfusion (HMP) using a novel clinically applicable perfusion system, which is compared to NRP with static cold storage (SCS). In a porcine model, a DCD setting was simulated, followed by either (1) NRP and SCS (2) NRP and HMP with the XVIVO Heart preservation system or (3) direct procurement (DPP) and HMP. After preservation, heart transplantation (HTX) was performed. After weaning from cardiopulmonary bypass (CPB), biventricular function was assessed by admittance and Swan-Ganz catheters. Only transplanted hearts in the HMP groups showed significantly increased biventricular contractility (end-systole elastance) 2 hour post-CPB (left ventricle absolute change: NRP HMP: +1.8 ± 0.56, p = 0.047, DPP HMP: +1.5 ± 0.43, p = 0.045 and NRP SCS: +0.97 ± 0.47 mmHg/ml, p = 0.21; right ventricle absolute change: NRP HMP: +0.50 ± 0.12, p = 0.025, DPP HMP: +0.82 ± 0.23, p = 0.039 and NRP SCS: +0.28 ± 0.26, p = 0.52) while receiving significantly less dobutamine to maintain a cardiac output >4l/min compared to SCS. Diastolic function was preserved in all groups. Post-HTX, both HMP groups showed significantly less increments in plasma troponin T compared to SCS. In DCD HTX, increased biventricular contractility post-HTX was only observed in hearts preserved with HMP. In addition, the need for inotropic support and signs of myocardial damage were lower in the HMP groups. DCD HTX can be successfully performed using DPP followed by preservation with HMP in a preclinical setting.

8 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJacob Marthinsen Seefeldt
Jacob Marthinsen Seefeldt
YLYaara Libai
Yaara Libai
KBKatrine Berg
Katrine Berg
NJNichlas Riise Jespersen
Nichlas Riise Jespersen
TLThomas Ravn Lassen
Thomas Ravn Lassen
NMNiels Moeslund
Niels Moeslund
Normothermic regional perfusion (NRP) allows assessment of therapeutic interventions prior to donation after circulatory death transplantation. Sodium-3-hydroxybutyrate (3-OHB) increases cardiac output in heart failure patients and diminishes ischemia–reperfusion injury, presumably by improving mitochondrial metabolism. We investigated effects of 3-OHB on cardiac and mitochondrial function in transplanted hearts and in cardiac organoids. Donor pigs (n = 14) underwent circulatory death followed by NRP. Following static cold storage, hearts were transplanted into recipient pigs. 3-OHB or Ringer’s acetate infusions were initiated during NRP and after transplantation. We evaluated hemodynamics and mitochondrial function. 3-OHB mediated effects on contractility, relaxation, calcium, and conduction were tested in cardiac organoids from human pluripotent stem cells. Following NRP, 3-OHB increased cardiac output (P < 0.0001) by increasing stroke volume (P = 0.006), dP/dt (P = 0.02) and reducing arterial elastance (P = 0.02). Following transplantation, infusion of 3-OHB maintained mitochondrial respiration (P = 0.009) but caused inotropy-resistant vasoplegia that prevented weaning. In cardiac organoids, 3-OHB increased contraction amplitude (P = 0.002) and shortened contraction duration (P = 0.013) without affecting calcium handling or conduction velocity. 3-OHB had beneficial cardiac effects and may have a potential to secure cardiac function during heart transplantation. Further studies are needed to optimize administration practice in donors and recipients and to validate the effect on mitochondrial function.

20 July 2022 in Artificial Organs
Verified
Journal Article
Open access
ZZZhang Long Zhang
Zhang Long Zhang
NMNiels Moeslund
Niels Moeslund
MHMichiel Andy Hu
Michiel Andy Hu
RHRoland Hoffmann
Roland Hoffmann
LVLeonie Harmina Venema
Leonie Harmina Venema
MEMichiel Elardus Erasmus
Michiel Elardus Erasmus
Background: Ex vivo lung perfusion (EVLP), is a platform that allows simultaneous testing and treatment of the lungs. However, use of EVLP is costly and requires access to lab animals and accompanying facilities. To increase the use of EVLP for research, we developed a method to perform EVLP using abattoir procured lungs. Furthermore, we were also able to significantly decrease costs.Methods: Six pair of lungs were procured from abattoir sheep. The lungs were then flushed and stored in ice for 3 h. A low‐flow (20% of cardiac output) approach, a tidal volume of 6 ml/kg bodyweight and total perfusion time of 3 h were chosen. Perfusion fluids and circuits were self‐made. Lung biopsies, perfusate collection, respiratory values, circulatory pressures were recorded and hourly blood gas analyses were performed.Results: Mean pO2 remained stable from 60 min (49.3 ± 7.1 kPa) to 180 min (51.5 kPa ± 8.0), p = 0.66. Pulmonary artery pressure remained ≤15 mm Hg and the left atrial pressure remained between 3 and 5 mm Hg and peak respiratory pressures ≤20 cmH2O. Lactate dehydrogenase increased from start (96.3 ± 56.4 U/L) to the end of perfusion (315.8 ± 85.0 U/L), p < 0.05. No difference was observed in ATP between procurement and post‐EVLP, 129.7 ± 37.4 μmol/g protein to 132.0 ± 23.4 μmol/g, p = 0.92.Conclusions: Sheep lungs, acquired from an abattoir, can be ex vivo perfused under similar conditions as lab animal lungs with similar results regarding e.g., oxygenation and ATP restoration. Furthermore, costs can be significantly reduced by making use of this abattoir model. By increasing accessibility and lowering costs for experiments using lung perfusion, more results may be achieved in the field of lung diseases.

Verified
Journal Article
Open access
PDF file
TSTimo Steinkühler
Timo Steinkühler
SYShuqi Yang
Shuqi Yang
MHMichiel A. Hu
Michiel A. Hu
JJJayant S. Jainandunsing
Jayant S. Jainandunsing
NJNeeltina M. Jager
Neeltina M. Jager
Gertrude Nieuwenhuijs-MoekeGertrude Nieuwenhuijs-Moeke
Gertrude Nieuwenhuijs-Moeke
Volatile anesthetics have been shown in different studies to reduce ischemia reperfusion injury (IRI). Ex vivo lung perfusion (EVLP) facilitates graft evaluation, extends preservation time and potentially enables injury repair and improvement of lung quality. We hypothesized that ventilating lungs with sevoflurane during EVLP would reduce lung injury and improve lung function. We performed a pilot study to test this hypothesis in a slaughterhouse sheep DCD model. Lungs were harvested, flushed and stored on ice for 3 h, after which EVLP was performed for 4 h. Lungs were ventilated with either an FiO2 of 0.4 (EVLP, n = 5) or FiO2 of 0.4 plus sevoflurane at a 2% end-tidal concentration (Cet) (S-EVLP, n = 5). Perfusate, tissue samples and functional measurements were collected and analyzed. A steady state of the target Cet sevoflurane was reached with measurable concentrations in perfusate. Lungs in the S-EVLP group showed significantly better dynamic lung compliance than those in the EVLP group (p = 0.003). Oxygenation capacity was not different in treated lungs for delta partial oxygen pressure (PO2; +3.8 (−4.9/11.1) vs. −11.7 (−12.0/−3.2) kPa, p = 0.151), but there was a trend of a better PO2/FiO2 ratio (p = 0.054). Perfusate ASAT levels in S-EVLP were significantly reduced compared to the control group (198.1 ± 93.66 vs. 223.9 ± 105.7 IU/L, p = 0.02). We conclude that ventilating lungs with sevoflurane during EVLP is feasible and could be useful to improve graft function.

23 October 2026 in Clinics
Verified
Journal Article
Open access
MRMayara Munhoz de Assis Ramos
Mayara Munhoz de Assis Ramos
MVMarina Vidal-Dos-Santos
Marina Vidal-Dos-Santos
SYShuqi Yang
Shuqi Yang
DKDominique Koerts
Dominique Koerts
MHMichiel Hu
Michiel Hu
HLHenri Leuvenink
Henri Leuvenink
Uncontrolled Donation after Circulatory Death (uDCD) has been considered an alternative to expand the lung donor pool. A key variable in these procedures is whether ventilation is maintained during the ischaemic interval. The present study evaluated the impact of ventilation during warm ischaemia in ovine DCD lungs, followed by functional assessment through Ex Vivo Lung Perfusion (EVLP). Ovine lungs were procured from a local slaughterhouse and flushed in situ. Lungs were then assigned to two groups: Ventilated (V) or Non-Ventilated (NV) during 120-minutes of warm ischaemia (WI), followed by 120-minutes of cold storage. EVLP was conducted for 240-minutes using a low-flow strategy, pressure-controlled ventilation, and a custom-made perfusion solution. Lung biopsies and perfusate samples were collected. Histopathological evaluation was performed; ventilatory and perfusion parameters were monitored. After 240-min of EVLP, both groups presented an increase in the compliance (Cdyn) (p = 0.0001), pO2 (p = 0.0047), pCO2 (p = 0.0155), and lactate (p = 0.0001), without differences between the groups. Histopathology analysis indicated that haemorrhage after WI was higher in NV (p < 0.001) than V. Inflammatory cytokines gene expression was increased in V vs. NV at the end-EVLP, but no differences were seen, 24h later. Ventilation did not confer a clear advantage in the functional status of the lungs after EVLP and may even be associated with transient increases in inflammatory and apoptotic responses. These findings suggest that immediate inflation alone may be sufficient to preserve graft quality prior to transplantation, and that preservation strategies should not primarily focus on mechanical ventilation.

4 April 2026 in JHLT Open
Verified
Journal Article
Open access
MHM.A. Hu
M.A. Hu
ZZZ.L. Zhang
Z.L. Zhang
RHR.F. Hoffmann
R.F. Hoffmann
TGTji Gan
Tji Gan
EVE.A.M. Verschuuren
E.A.M. Verschuuren
MEM.E. Erasmus
M.E. Erasmus
Ex vivo lung perfusion (EVLP) is a well-established method for assessing and reconditioning donor lungs before lung transplantation (LTx). Remarkably, clinical outcomes between standard criteria and marginal donor lungs after EVLP are similar despite differences in lung quality. Therefore, we explored several biomarkers during EVLP in this study. Novel findings could guide future interventions to enhance lung quality and expand the donor pool. EVLP was performed for ≥180 min with 18 standard criteria (logistical) and 15 marginal donor lungs. The biomarkers were measured in the perfusate after 90 and 180 min: d-dimer, Prothrombin Fragment 1+2 (F1+2), Plasminogen Activator Inhibitor-1 (PAI-1), urokinase Plasminogen Activator Receptor (uPAR), IL-1β, IL-6, IL-8, TNF-α, syndecan-1, hyaluronan and Vascular Cell Adhesion Molecule-1 (VCAM-1). In the logistical and marginal group, 16/18 and 12/15 were transplanted, respectively. All biomarkers increased significantly during EVLP. Remarkably, d-dimer, F1+2, uPAR, IL-6, IL-8, syndecan-1, hyaluronan, and VCAM-1 were significantly higher in the marginal group. Declined donor lungs had significantly higher levels of syndecan-1 and hyaluronan than all transplanted donor lungs. Lung function during EVLP and primary graft dysfunction (PGD) were similar between the transplanted standard and marginal lungs. No significant correlations with PGD were observed. Marginal donor lungs sustained more injury as reflected in higher levels of fibrin degradation, inflammation, glycocalyx shedding, and endothelial activation. In addition, declined donor lungs exhibited significantly higher glycocalyx shedding. Therefore, both logistical and marginal donor lungs could potentially benefit from thrombolysis, inflammation-reducing therapy, and endothelial preservation during EVLP to enhance lung quality.